JP2025516465A5 - - Google Patents
Info
- Publication number
- JP2025516465A5 JP2025516465A5 JP2024561686A JP2024561686A JP2025516465A5 JP 2025516465 A5 JP2025516465 A5 JP 2025516465A5 JP 2024561686 A JP2024561686 A JP 2024561686A JP 2024561686 A JP2024561686 A JP 2024561686A JP 2025516465 A5 JP2025516465 A5 JP 2025516465A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- seq
- tcr
- nucleic acid
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/744,568 US20220305102A1 (en) | 2017-06-30 | 2022-05-13 | Treatment of haematological malignancies |
| US17/744,568 | 2022-05-13 | ||
| PCT/NL2023/050268 WO2023219510A1 (en) | 2022-05-13 | 2023-05-15 | Treatment of haematological malignancies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025516465A JP2025516465A (ja) | 2025-05-30 |
| JP2025516465A5 true JP2025516465A5 (OSRAM) | 2026-04-22 |
Family
ID=86609466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024561686A Pending JP2025516465A (ja) | 2022-05-13 | 2023-05-15 | 血液悪性腫瘍の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250304651A1 (OSRAM) |
| EP (1) | EP4522282A1 (OSRAM) |
| JP (1) | JP2025516465A (OSRAM) |
| KR (1) | KR20250010024A (OSRAM) |
| CN (1) | CN119256084A (OSRAM) |
| CA (1) | CA3250741A1 (OSRAM) |
| WO (1) | WO2023219510A1 (OSRAM) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6750325B1 (en) | 1989-12-21 | 2004-06-15 | Celltech R&D Limited | CD3 specific recombinant antibody |
| GB9206422D0 (en) | 1992-03-24 | 1992-05-06 | Bolt Sarah L | Antibody preparation |
| DK1629011T3 (da) | 2003-05-31 | 2010-05-03 | Micromet Ag | Humane anti-humane-DC3-bindingsmolekyler |
| EP3215522B1 (en) | 2014-11-03 | 2021-12-01 | Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum | T cell receptors directed against bob1 and uses thereof |
| US20220305102A1 (en) * | 2017-06-30 | 2022-09-29 | Academisch Ziekenhuis Leiden (H.O.D.N. Leids Universitair Medisch Centrum) | Treatment of haematological malignancies |
| CA3067772A1 (en) * | 2017-06-30 | 2019-01-03 | Marieke GRIFFIOEN | Treatment of haematological malignancies |
| CA3173527A1 (en) * | 2020-03-10 | 2021-09-16 | Massachusetts Institute Of Technology | Methods for generating engineered memory-like nk cells and compositions thereof |
-
2023
- 2023-05-15 US US18/865,485 patent/US20250304651A1/en active Pending
- 2023-05-15 JP JP2024561686A patent/JP2025516465A/ja active Pending
- 2023-05-15 EP EP23727701.7A patent/EP4522282A1/en active Pending
- 2023-05-15 KR KR1020247040550A patent/KR20250010024A/ko active Pending
- 2023-05-15 CA CA3250741A patent/CA3250741A1/en active Pending
- 2023-05-15 WO PCT/NL2023/050268 patent/WO2023219510A1/en not_active Ceased
- 2023-05-15 CN CN202380040121.6A patent/CN119256084A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dürkop et al. | Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease | |
| JP7340127B2 (ja) | がんに対する免疫療法で使用するための形質移入ｔ細胞およびｔ細胞受容体 | |
| JP2022502056A5 (OSRAM) | ||
| JP2022109953A5 (OSRAM) | ||
| JP6929867B2 (ja) | がんに対する免疫療法で使用するための形質移入ｔ細胞およびｔ細胞受容体 | |
| JP2021520198A5 (OSRAM) | ||
| CN106459990B (zh) | 三功能t细胞抗原偶联物及其制备方法和用途 | |
| CN108395479B (zh) | 一种有关kras基因突变的t细胞受体 | |
| Hasegawa et al. | SFA-1, a novel cellular gene induced by human T-cell leukemia virus type 1, is a member of the transmembrane 4 superfamily | |
| Campos-Lima et al. | Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus | |
| JP2021533777A5 (OSRAM) | ||
| JP2022527635A5 (OSRAM) | ||
| TW202239764A (zh) | 轉染 t 細胞和 t 細胞受體用於癌症免疫治療 | |
| JP2003511080A (ja) | 免疫治療組成物調製用のレンチウイルスベクター | |
| JP2022512326A5 (OSRAM) | ||
| CN112689642B (zh) | 具有各种不同的构建物优化的t细胞抗原偶联物 | |
| JP7835765B2 (ja) | Ｂｃｍａに特異的に結合する抗体およびその使用 | |
| JP2024520427A5 (OSRAM) | ||
| JP2021531834A5 (OSRAM) | ||
| JP2025063321A5 (OSRAM) | ||
| WO2021102624A1 (en) | Covalent protein drugs developed via proximity-enabled reactive therapeutics (perx) | |
| JP7742354B2 (ja) | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| JP2025537239A5 (OSRAM) | ||
| CN111479925A (zh) | 具有y182t突变的t细胞-抗原偶联物及其方法和用途 | |
| CN110257338A (zh) | 嵌合细胞因子受体 |